Related Experiment Video
Updated: Jul 20, 2026

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
Published on: December 9, 2022
Soluble CD163: An age-dependent, anti-inflammatory biomarker predicting outcome in sepsis
Critical Care Medicine
|September 20, 2006
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The Cellular Response Capacity as Diagnostic Head Start in Neutrophil Endotoxemia Sensing.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Impact of cardiopulmonary bypass on cefuroxime plasma and interstitial tissue concentrations in patients undergoing cardiac bypass surgery-a prospective controlled clinical trial.
The Journal of antimicrobial chemotherapy·2026
The cellular response capacity (CRC) as a novel immunomonitoring approach in sepsis.
Military Medical Research·2026
Influence of Age in End-of-Life Practices in Worldwide ICUs (ETHICUS-2): A Prospective Observational Study.
Critical care medicine·2026
Ketamine for Analgosedation in Mechanically Ventilated Adults: A Double-Blind Randomized Trial.
Critical care medicine·2026
Predictors of Critical Illness During Different COVID-19 Pandemic Periods Compared With Seasonal Influenza.
Critical care medicine·2026
Healthcare Encounters in the Week Preceding a Sepsis Hospitalization in Pediatric Patients.
Critical care medicine·2026
An integrative clinical-molecular model as an auxiliary predictive tool for glioma malignancy grade.
Neurological research·2026
Evaluating adenoma detection and miss rates in tandem colonoscopy: Limitations of surrogate quality indicators.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University·2026
Predicting Radioiodine Therapy Response in Advanced and Recurrent Thyroid Cancer.
Endocrine-related cancer·2026
Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck.
Cancer cytopathology·2026
PGR expression as a pharmacogenomic companion biomarker to GENE70-derived genomic risk in ER-positive/HER2-negative breast cancer.
Pakistan journal of pharmaceutical sciences·2026